Home
Conditions
Somatostatinoma

Clinical trial condition

Somatostatinoma

Explore clinical trials studying Somatostatinoma. Study availability and eligibility vary by location and protocol.

36 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Somatostatinoma trial results

Completed

A Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET)

NCT02806648

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +16 more
Locations: ICO L'Hospitalet de Llobregat, Barcelona, Spain

C. H. de Navarra Pamplona, Navarre, Spain

H.U.C de Asturias Oviedo, Principality of Asturias, Spain

H. Vall d´Hebron Barcelona, Spain

View Trial Details

Completed

Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers

NCT01528774

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +42 more
Locations: Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States

View Trial Details

Completed

Capecitabine and Temozolomide for Neuroendocrine Cancers

NCT00869050

Conditions: Adenocarcinoma, Carcinoid Tumor, Carcinoma, +32 more
Locations: Columbia University Medical Center New York, United States

View Trial Details

Completed

Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma

NCT01204476

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +52 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

NCT00416767

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +24 more
Locations: Not specified

View Trial Details

Completed

Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

NCT00131911

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +28 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

NCT00538850

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +260 more
Locations: InSys Therapeutics, Incorporated Chandler, Arizona, United States

View Trial Details

Completed

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

NCT00096083

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +63 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

View Trial Details

Completed

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

NCT00602082

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
Locations: Basildon University Hospital Basildon, England, United Kingdom

Addenbrooke's Hospital Cambridge, England, United Kingdom

Cookridge Hospital Leeds, England, United Kingdom

Leicester Royal Infirmary Leicester, England, United Kingdom

View all 17 locations

View Trial Details

Completed

Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors

NCT00027638

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +30 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Somatostatinoma

Somatostatinoma trial results

Related conditions